Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1830 participants.

Also called NCT02137187

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,830 participants (planned count) (from the registry)
Sponsor
Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella (from the registry)
Registry
  • NCT NCT02137187
Other papers using this trial's data
  • AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial European heart journal, 2021-12-07 DOI, PubMed 34453840 PubMed links an erratum for this paper. Erratum: PMID 34654929; Erratum: PMID 34878510

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02137187. Randomized; no masking; primary purpose treatment. Start 2014-10-15 (actual); primary completion 2021-05-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure
Acronym
APAF-CRT
Condition
Permanent Atrial Fibrillation
Intervention (Procedure)
AV junction ablation
Intervention (Device)
CRT
Intervention (Drug)
Optimized drug therapy
Intervention (Device)
ICD
Lead sponsor
Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella (class: other)

Record details

Record id
cardio:ct-nct02137187
Content hash
a1a555971a53414002e11c182b6b06cfbb065b421280edfc05e9ea231fce9a8c